argenx SE | Kostnadene For Salg



Cost Of Sales Endring Dato
AstraZeneca USD 2.72B 263M 2024-12
Galapagos EUR 112.93M 112.91M 2024-12
Genmab DKK 337M 64M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
GRIFOLS EUR 1.21B 143.12M 2024-12
Hikma Pharmaceutical USD 813M 39M 2024-06
Qiagen NV USD 187.91M 16.67M 2024-12
UCB EUR 425.5M 479.5M 2024-06



argenx SE Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.